When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of the weight loss drugs. Now, the FDA is clamping down.
Weight loss drugs may become harder to get. What does that mean for patients? | On Point | Podcast - Listen or read transcript on Metacast